FDA-approved cholesterol medicine may help prevent antibiotic resistance

Antimicrobial resistance, including bacteria that have evolved to defy antibiotics, is one of the top 10 global public health threats humanity faces, according to the World Health Organization. A Penn State-led multidisciplinary collaboration may have found a solution in cholestyramine, an oral drug already approved by the U.S. Food and Drug Administration to reduce cholesterol levels and remove bile acids associated with liver diseases.